OUR QUALITY: ISO 9001:2015 | ISO 14001:2015 | OHSAS 18001:2007 | ISO Guide 34:2009 | ISO/IEC 17025:2005 |
|
We speak your language |
OUR QUALITY: ISO 9001:2015 | ISO 14001:2015 | OHSAS 18001:2007 | ISO Guide 34:2009 | ISO/IEC 17025:2005 |
|
We speak your language |
Search by CAS No , Chemical Name or Molecular Formula
CAS No.
:
1132709-16-0
Molecular Weight
:
384.24
Molecular Formula
:
C19H25BN4O4
Purity
:
99.47 %
Long Term Storage
:
2-8°C
Inventory Status
:
Purchase Online |
(1S,3R)-Bortezomib is an diastereomer of Bortezomib , the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus
(1S,2R) Bortezomib;[(1S)-3-methyl-1-[(2R)-3-phenyl-2-(pyrazin-2-ylformamido)propanamido]butyl]boronc Acid
Nawrcki, S.T., et al:cacer Reseach, 65, 11510 (2005); Drahlc.:chem. and Eng. News, 87, 41 (2009)
We normally respond within 8 hours.
This page contains information about (1S,2R) Bortezomib Cas # 1132709-16-0 and its Chiral Standards.
(1S,2R) Bortezomib (1S,2R) Bortezomib Worldwide Suppliers of (1S,2R) Bortezomib https://www.clearsynth.com/en/CSO20087.html Chiral Standards Clearsynth 1132709-16-0
Regular price: $1000 In stock
Product rating: 9 (1S,2R) Bortezomib based on 20 ratings
Keywords: Chiral Standards (1S,2R) Bortezomib;[(1S)-3-methyl-1-[(2R)-3-phenyl-2-(pyrazin-2-ylformamido)propanamido]butyl]boronc Acid CS-O-20087 (1S,2R) Bortezomib Bortezomib 1132709-16-0 384.24 C19H25BN4O4
- Bortezomib : Stable Isotopes
- Bortezomib : Chiral Standards
Specific product requirements
CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, Ontario,
Canada L5K 1B3
T :
+1-289-729-0060
CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
Hyderabad- 500076,
Telangana, India.
T :
+91-40-27155481
CLEARSYNTH LABS LTD.
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
India
T :
+91-22-45045945
Terez krt., 31, 1/13
H-1067 Budapest
Hungary,
T :
+36-1-7985-435
Print Version
